Socio-medical situation for long-term survivors of Hodgkin's disease: A survey of 459 patients treated at one institution

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1865-1870

  Abrahamsen, A F ^a   Loge, J H ^b   Hannisdal, E ^a   Holte, H ^a   Kvaloy S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Employment problems; Family problems; Fertility; Hodgkin's disease

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CAREER; CONTROLLED STUDY; DISTRESS SYNDROME; EARLY MENOPAUSE; EDUCATION; EMPLOYMENT; FAMILY LIFE; FATIGUE; FEMALE; HODGKIN DISEASE; HUMAN; INFERTILITY; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; PRIORITY JOURNAL; SELF REPORT; SEXUAL DYSFUNCTION; SOCIAL PSYCHOLOGY; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; CAREER CHOICE; DISABLED PERSONS; DISEASE-FREE SURVIVAL; EMPLOYMENT; FAMILY HEALTH; FEMALE; HODGKIN DISEASE; HUMANS; INFERTILITY; INTERPERSONAL RELATIONS; MALE; MARRIAGE; MENSTRUATION DISTURBANCES; MIDDLE AGED; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SURVIVORS;

EID: 0032212448     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00269-X     Document Type: Article

References (39)

1. 1. Urba JW, Longo DL. Hodgkin's disease. N Engl J Med 1992, 326, 678-687.
2. 2. Rosenberg SA. The treatment of Hodgkin's disease. Ann Oncol 1994, 5(Suppl. 2), 817-821.
3. 3. Abrahamsen AF, Egeland T, Hansen S, et al. Hodgkin's disease in national and hospital material. Eur J Cancer 1997, 33, 2380-2383.
4. 4. Fobair P, Hoppe R, Bloom J, et al. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 1986, 4, 805-814.
5. 5. Devlen J, Maguire P, Phillips P, et al. Psychological problems associated with diagnosis and treatment of lymphomas. Prospective study. Br Med J 1987, 295, 955-957.
6. 6. Siegel K, Christ GH. Hodgkin's disease survivorship: psychosocial consequences. In Lacher MD, Mortimer J, Redman JR, eds. Hodgkin's Disease; the consequences of survival. Philadelphia Pennsylvania, Lea & Febiger, 1990, 383-399.
7. 7. Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease. A report of the international data base on Hodgkin's disease. Semin Oncol 1990, 17, 758-768.
8. 8. Young RC, Bookman MA, Longo DL. Late complications of Hodgkin's disease management. J Natl Cancer Inst Monogr 1990, 10, 55-60.
9. 9. Abrahamsen AF, Loge JH, Hannisdal E, et al. Medical problems after treatment of Hodgkin's disease. Acta Oncol 1998, (in press).
10. 10. Yellen SB, Cella DF, Bonomi A. Quality of life in patients with Hodgkin's disease. Oncology 1993, 7, 41-52.
11. 11. Kornblith AB, Anderson J, Cella DF, et al. Hodgkin's disease survivors at increased risk for problems in psychosocial adaptions. Cancer 1992, 70, 2214-2224.
12. 12. van Tulder MW, Aaronsen NK, Bruning PF. The quality of life of long time survivors in Hodgkin's disease. Ann Oncol 1994, 5, 153-158.
13. 13. Norum J, Wist EA. Quality of life in survivors of Hodgkin's disease. Quality of Life Research 1996, 5, 367-374.
14. 14. Norum J, Wist E. Psychological distress in survivors of Hodgkin's disease. Support Care Cancer 1996, 4, 191-195.
15. 15. Joly F, Henry-Amar M, Arveux P, et al. Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study. J Clin Oncol 1996, 14, 2444-2453.
16. 16. Bloom JR, Fobair P, Gritz E, et al. Psychosocial outcomes of cancer. A comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1993, 11, 979-988.
17. 17. Loge JH, Abrahamsen AF, Ekeberg Ø, et al. Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Br J Cancer 1997, 76, 791-796.
18. 18. Loge JH, Abrahamsen AF, Ekeberg Ø, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1998 (inpress).
19. 19. Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. JAMA 1979, 242, 1877-1881.
20. 20. Horning SJ, Hoppe RT, Kaplan HS, et al. Female reproductive potential after treatment of Hodgkin's disease. N Engl J Med 1981, 304, 1378-1382.
21. 21. Asbjørnsen G, Molne K, Klepp O, Aakvaag A. Testicular function after combination chemotherapy for Hodgkin's disease. Scand J Haematol 1976, 16, 66-69.
22. 22. Waxman JHX, Terry YA, Wrigley PFM, et al. Gonadal function in Hodgkin's disease. Long term follow up of chemotherapy. Br Med J 1982, 285, 1612-1613.
23. 23. Whitehead E, Shalet SM, Blackledge G, et al. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 1982, 49, 418-422.
24. 24. Vivani S, Santoro A, Ragri E. Gonadal toxicity after combined chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985, 21, 601-605.
25. 25. Wasserman AL, Thompson EI, Williams JA, et al. The psychological status of survivors of childhood/adolescent Hodgkin's disease. Am J Dis Child 1987, 141, 626-631.
26. 26. Lukes RJ, Craver LF, Hall TC, et al. Reports of the nomenclature committee. Cancer Res 1966, 26, 1311.
27. 27. Carbone PP, Kaplan HS, Musshoff K, et al. Reports of the committee on Hodgkin's disease staging classification. Cancer Res 1971, 31, 1860-1861.
28. 28. Loge JH, Ekeberg Ø, Kaasa S. Fatigue in the general population-normative data. J Psychosomatic Res 1998, 45, 53-65.
29. 29. Jetne V. Treatment of Hodgkin's disease by radiation therapy. Acta Radiol 1972, 313, 67-75.
30. 30. Sutcliffe SB, Wrigley RF, Peto J, et al. MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J 1978, I, 679-683.
31. 31. McElwain TJ, Toy J, Smith F, et al. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer 1977, 36, 276-290.
32. 32. Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboximide versus MOPP. Cancer 1975, 36, 252-259.
33. 33. Santoro A, Bonadonna G, Bonfante V, et al. Alternating drug combinations in the treatment of Hodgkin's disease. N Engl J Med 1982, 306, 770-775.
34. 34. Zittoun R, Eghbali H, Audebert A, et al. Association d'epirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiotherapie dans les stades localises de la maladie de Hodgkin. Bull Cancer 1987, 74, 151-157.
35. 35. Statistical Yearbook of Norway 1993. 112th issue Oslo-Kongsvinger, 1993, 45.
36. 36. Lund MB, Kongerud J, Nome O, et al. Lung function impairment in long-time survivors of Hodgkin's disease. Ann Oncol 1995, 6, 495-503.
37. 37. Lund MB, Ihlen H, Voss BMR, et al. Radiation-induced valvular dysfunction after curative treatment of Hodgkin's disease. Heart 1996, 75, 591-595.
38. 38. Lund MB, Kongerud J, Nome O, et al. Cardio-pulmonary sequelae after treatment of Hodgkin's disease: increased risk in females? Ann Oncol 1996, 7, 257-264.
39. 39. Yelin E, Nevitt M, Ebstein LD. Toward an epidemiology of work disability. Milbank Mem Fund 1980, 58, 387-415.